In whole-cell patch-clamp recordings, 10 μM clemizole inhibits heteromeric TRPC1:C5 channels, and 50 μM clemizole partially inhibits riluzole-activated currents in the U-87 glioblastoma cell line. The gene discussed is TRPC1; the disease is glioblastoma.